The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

The plan would need to be supported by the incoming Trump administration, which has vowed to cut costs across the federal government.

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...

WHEN IT COMES to losing weight, belly fat will present the biggest challenge. Guys are prone to storing excess pounds around the middle thanks to a slew of factors—from age to genetics to stress ...

We certainly love sharing people’s journeys on Loving Living Local and Dr. Kells’ Weight Loss program has those stories.

Millions of Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The proposal would let patients get Wegovy, Ozempic and related drugs for obesity, which Medicare and Medicaid does not cover ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

The Biden administration announced Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to ...